TNFSF11

TNF Superfamily Member 11 (RANKL) – Key Regulator of Bone Remodeling and Immune Function

Gene Information Card

Symbol TNFSF11
Full Name TNF Superfamily Member 11
Gene Type Protein coding
Chromosomal Location 13q14.11
NCBI Gene ID 8600 ncbi.nlm.nih.gov/gene/8600
Ensembl ID ENSG00000120659
UniProt ID O14788
OMIM ID 602642
HGNC ID 11926
Aliases RANKL, OPGL, TRANCE, ODF, CD254, sOdf

Description

TNFSF11 encodes RANKL (Receptor Activator of Nuclear Factor-κB Ligand), a member of the tumor necrosis factor (TNF) superfamily. RANKL is a transmembrane protein essential for osteoclast differentiation, activation, and survival. It binds to its receptor RANK (TNFRSF11A) on osteoclast precursors, triggering NF-κB and MAPK signaling pathways. RANKL also plays roles in immune regulation, lymph node development, and mammary gland formation. Alternative splicing produces soluble and membrane-bound isoforms.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Osteopetrosis, autosomal recessive 2 (OPTB2) Loss-of-function mutations in TNFSF11 impair RANKL-mediated osteoclastogenesis, leading to dense but brittle bones due to defective bone resorption. ClinVar, OMIM #612301
Paget disease of bone (PDB) Gain-of-function or overexpression of RANKL enhances osteoclast activity, causing abnormal bone remodeling, pain, and deformities. OMIM #602642, NCBI Gene
Osteoporosis Increased RANKL/OPG ratio promotes excessive bone resorption, contributing to reduced bone mineral density and fracture risk. ClinVar, literature
RANKL deficiency Homozygous loss-of-function mutations cause severe osteopetrosis with lack of osteoclasts, often fatal in infancy. OMIM #612301

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 0.0 Not detected
Lymph node 0.0 Not detected
Spleen 0.0 Not detected
Thymus 0.0 Not detected
Tonsil 0.0 Not detected
Cell Line Expression
Cell Line nTPM Notes
HEK 293 0.0 Not expressed
HeLa 0.0 Not expressed
K562 0.0 Not expressed
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.525C>A (p.Tyr175Ter) Nonsense Rare Loss of function; truncation of RANKL protein
c.686G>A (p.Arg229Gln) Missense Rare Loss of function; impaired receptor binding
c.827T>C (p.Leu276Pro) Missense Rare Loss of function; disrupts protein folding
c.940C>T (p.Arg314Trp) Missense Rare Loss of function; reduced secretion
Mutation functional classification

Loss of Function (LOF)

Mutations that truncate or destabilize RANKL, impairing osteoclast differentiation and causing osteopetrosis.

Gain of Function (GOF)

Not well documented; overexpression or activating mutations may contribute to Paget disease or osteoporosis.

Dominant Negative (DN)

Not reported for TNFSF11.

Gene Ontology (GO)

• GO:0005125 – cytokine activity • GO:0005164 – tumor necrosis factor receptor binding
• GO:0005515 – protein binding • GO:0030154 – cell differentiation
• GO:0043531 – ADP binding • GO:0046872 – metal ion binding

Pathways

RANKL/RANK signaling pathway (Reactome: R-HSA-5663205)
Osteoclast differentiation (KEGG: hsa04380)
NF-κB signaling pathway (KEGG: hsa04064)
MAPK signaling pathway (KEGG: hsa04010)

Protein Summary

RANKL (O14788) is a 317-amino acid type II transmembrane protein with an extracellular TNF homology domain. It exists as a membrane-bound homotrimer or a soluble form generated by proteolytic cleavage. RANKL binds to RANK (TNFRSF11A) and the decoy receptor OPG (TNFRSF11B). It is essential for osteoclastogenesis, lymph node organogenesis, and mammary gland development. Dysregulation leads to bone diseases.

Related Products

Product name Cat.No. Species Gene ID
TNFSF11 Knockout HEK293 Cell Line EDC07596 Human 8600 Details Get a Quote
TNFSF11 Knockout MLO-Y4 Cell Line EDJ-KZ54 Mouse 8600 Details Get a Quote
TNFSF11 Knockout HeLa Cell Line EDJ-KQ54949 Human 8600 Details Get a Quote
TNFSF11 Knockout A-549 Cell Line EDJ-KQ63435 Human 8600 Details Get a Quote
TNFSF11 Knockout HCT 116 Cell Line EDJ-KQ71901 Human 8600 Details Get a Quote
Displaying Records 1 To 5 Of 5 Records
Contact Us
*
*
*
*
How did you hear about us: